Exhalation delivery system with fluticasone improves quality of life and health status: pooled analysis of phase 3 trials NAVIGATE I and II

BACKGROUND: Chronic rhinosinusitis with or without nasal polyps (CRSwNP/CRSsNP) seriously impairs health‐related quality of life (HRQoL). This analysis describes the impact of the exhalation delivery system with fluticasone (EDS‐FLU) on HRQoL, assessed by the 36‐item Short‐Form Health Survey version...

Descripción completa

Detalles Bibliográficos
Autores principales: Soler, Zachary M., Colman, Sam, Velez, Fulton F., Schlosser, Rodney J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818430/
https://www.ncbi.nlm.nih.gov/pubmed/32445277
http://dx.doi.org/10.1002/alr.22573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818430/
https://www.ncbi.nlm.nih.gov/pubmed/32445277
http://dx.doi.org/10.1002/alr.22573

Ejemplares similares